Results 231 to 240 of about 41,114 (259)
Some of the next articles are maybe not open access.
Endocannabinoids and their actions
2002Endocannabinoids are a new class of lipid mediators, which includes amides and esters of long-chain polyunsaturated fatty acids. Anandamide (I) and 2-arachidonoylglycerol (II) are the main endogenous agonists of cannabinoid receptors, able to mimic several pharmacological effects of delta 9-tetrahydrocannabinol (III), the active principle of Cannabis ...
Maccarrone M, Finazzi-Agro A
openaire +3 more sources
ENDOCANNABINOIDS AND THE NEUROCHEMISTRY OF GLUTTONY
Journal of Neuroendocrinology, 2008SummaryCannabis exerts its actions by mimicking ‘endocannabinoid’ neuromodulators at CB1 receptors in brain and peripheral tissues. The endocannabinoids both stimulate appetite by increasing food craving and enjoyment and promote the deposition of energy as fat in adipose tissues. These findings have raised the possibility of CB1 antagonists as a novel
openaire +2 more sources
2007
Abstract The endocannabinoids are part of a large family of lipid signaling molecules derived from arachidonic acid, including the prostaglandins and leukotrienes, which are important mediators of inflammation. Far less is known about the newer members of the endocannabinoid group, and it remains unclear whether they all play important ...
openaire +1 more source
Abstract The endocannabinoids are part of a large family of lipid signaling molecules derived from arachidonic acid, including the prostaglandins and leukotrienes, which are important mediators of inflammation. Far less is known about the newer members of the endocannabinoid group, and it remains unclear whether they all play important ...
openaire +1 more source
Endocannabinoid-Based Therapies
Annual Review of Pharmacology and Toxicology, 2022Daniele Piomelli, Alex Mabou Tagne
exaly
Enhanced endocannabinoid tone as a potential target of pharmacotherapy
Life Sciences, 2018Marek Toczek, Barbara Malinowska
exaly
Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors
Pharmacology & Therapeutics, 2011Antonia Serrano, Loren H Parsons
exaly
Endocannabinoid system imbalance in the postmortem prefrontal cortex of subjects with schizophrenia
Journal of Psychopharmacology, 2019Luis F. Callado +2 more
exaly
Beyond Cannabis: Plants and the Endocannabinoid System
Trends in Pharmacological Sciences, 2016Ethan Russo
exaly

